US EditionSouth Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs
- South Africa, Colombia, and other countries are challenging drugmakers' policies that prevent affordable treatment for tuberculosis and HIV, potentially increasing access to lifesaving medicines.
- South Africa's investigation into Johnson & Johnson 's pricing policies prompted the company to drop the patent for the TB drug bedaquiline in more than 130 countries. Colombia also declared a compulsory license for the HIV drug dolutegravir.
- AIDS-Related deaths in Africa were exacerbated by limited access to medicines in the past. Now, efforts are being made globally to address this issue, with calls for J&J to drop patents in Belarus, Ukraine, and Brazil.
24 Articles
24 Articles
South Africa, Colombia Fighting Drugmakers Over Access to TB, HIV Drugs
South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach toward drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV. Experts see it as a shift in how such countries deal with pharmaceutical behemoths and say it could trigger more efforts to make lifesaving medicines more widely available. In the COVID-19 …
South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs
South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV.
South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs
CAPE TOWN, South Africa (AP) — South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to mill
South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs
CAPE TOWN, South Africa (AP) — South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to mill
South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs
CAPE TOWN, South Africa (AP) — South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to mill
South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs
CAPE TOWN, South Africa (AP) — South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to mill
Coverage Details
Bias Distribution
- 57% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
